The injectable Winny 50 is the latest Valkyrie Pharma product to be selected for chemical analysis.
Valkyrie Pharmaceutical’s stanozolol product has been selected by AnabolicLab for testing in its latest round of analyses. The particular product, Winny 50, is an injectable version of the orally-active stanozolol.
Valkyrie Pharma Winny 50 listed 50 milligrams of stanozolol per milliliter on the product label. AnabolicLab submitted product samples to SIMEC for quantitative dosage testing.
The SIMEC laboratory analysis revealed that Winny 50 actually contained 47.3 mg/ml of stanozolol. This is an excellent result that easily passes AnabolicLab criteria. It even surpasses our own preference for products that are dosed within 10% of the label claim.
New lab report: Valkyrie Pharmaceutical Winny 50 Lab Test Results https://t.co/x93VcqBIBQ #harmreduction #steroids
— Anabolic Lab (@AnabolicLab) July 29, 2016
Valkyrie Pharmaceutical products generally meet the label claims for the active ingredients.
AnabolicLab has analyzed four products manufactured by Valkyrie Pharmaceutical. The products include Winny 50, Deca 300, Oxyject 50, and Trenbolone E200.
Three of the products were accurately dosed and consistent with AnabolicLab standards. However, one product was not. Trenbolone E200 was approximately 25% overdosed.
Consumers are generally happy with overdosed products. They rarely feel cheated. Nonetheless, products that are significantly overdosed (or underdosed) are not indicative of the best quality control practices.
